top of page
highresgif.gif

  • Cell and gene therapy

  • Genetically engineered T cells

  • Personalized Medicine 

  • Worldwide acceptance 

CAR T-cells: The living drug

More about CAR-T therapy

Our Product Pipeline

Relapsed/refractory B-cell lymphomas & B-acute lymphoblastic leukaemia

Currently available for ex-India out-licensing partnerships

NexCAR19 (Talicabtagene autoleucel)

2023

Relapsed/refractory Multiple Myeloma ​

Chequered Flag_edited.png

2026

Glioblastoma multiforme, Neuroblastoma​

Chequered Flag_edited.png

2027

GEJ, Gastric tumours

Chequered Flag_edited.png

2028

© 2023 by immunoact.com

bottom of page